ALLK Allakos Inc. Stock Quote

ALLK [NASD]

Index	-	P/E	-	EPS (ttm)	-3.10	Insider Own	1.30%	Shs Outstand	51.51M	Perf Week	-4.97%
Market Cap	5.21B	Forward P/E	-	EPS next Y	-4.59	Insider Trans	-44.13%	Shs Float	47.08M	Perf Month	-5.10%
Income	-153.50M	PEG	-	EPS next Q	-0.88	Inst Own	95.40%	Short Float	6.80%	Perf Quarter	-35.51%
Sales	-	P/S	-	EPS this Y	-64.20%	Inst Trans	-5.29%	Short Ratio	15.06	Perf Half Y	-0.18%
Book/sh	12.70	P/B	7.80	EPS next Y	-17.60%	ROA	-28.80%	Target Price	135.88	Perf Year	32.08%
Cash/sh	12.54	P/C	7.90	EPS next 5Y	-10.50%	ROE	-30.80%	52W Range	62.21 - 157.98	Perf YTD	-29.22%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-36.52%	Beta	-
Dividend %	-	Quick Ratio	29.80	Sales past 5Y	-	Gross Margin	-	52W Low	61.20%	ATR	5.31
Employees	125	Current Ratio	29.80	Sales Q/Q	-	Oper. Margin	-	RSI (14)	40.96	Volatility	7.11% 4.87%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-70.00%	Profit Margin	-	Rel Volume	0.54	Prev Close	99.09
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 10 AMC	Payout	-	Avg Volume	212.50K	Price	100.28
Recom	2.10	SMA20	-4.94%	SMA50	-9.74%	SMA200	-5.71%	Volume	79,941	Change	1.20%

Feb-24-21

Initiated

Cantor Fitzgerald

Overweight

$218

Jan-15-21

Initiated

BofA Securities

Buy

$145

Dec-21-20

Initiated

SVB Leerink

Outperform

$150

Feb-27-20

Initiated

Barclays

Underweight

$36

Feb-04-20

Resumed

Goldman

Neutral

$89 → $94

Aug-13-18

Initiated

William Blair

Outperform

Aug-13-18

Initiated

Jefferies

Buy

$53

Aug-13-18

Initiated

Goldman

Neutral

$31

May-10-21 04:01PM	Allakos Reports First Quarter 2021 Financial Results and Provides Business Update GlobeNewswire -5.92%
Apr-19-21 04:01PM	Allakos Appoints Baird Radford as Chief Financial Officer GlobeNewswire
Mar-30-21 08:00AM	Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the 2021 DDW Annual Meeting GlobeNewswire
Mar-01-21 08:00AM	Allakos Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update GlobeNewswire
Feb-17-21 02:22AM	UPDATE 2-Sweden's Sinch to buy communications firm Inteliquent for $1.14 bln Reuters
Jan-13-21 11:16PM	Here's Why We're Not At All Concerned With Allakos' (NASDAQ:ALLK) Cash Burn Situation Simply Wall St.
Jan-06-21 11:16AM	Are Options Traders Betting on a Big Move in Allakos (ALLK) Stock? Zacks
Dec-22-20 04:05PM	Allakos Appoints Natalie Holles to its Board of Directors GlobeNewswire
Dec-21-20 10:07AM	Benzinga's Top Upgrades, Downgrades For December 21, 2020 Benzinga +10.29%
Dec-10-20 10:33PM	Is ALLK A Good Stock To Buy Now? Insider Monkey
Nov-09-20 08:01AM	Allakos Reports Third Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
Nov-02-20 08:00AM	Allakos Announces Presentation from its Eosinophilic Gastrointestinal Diseases Program at the American College of Gastroenterology (ACG) 2020 Annual Scientific Meeting GlobeNewswire -7.65%
Oct-28-20 08:20PM	Allakos Announces Pricing of Public Offering of Common Stock GlobeNewswire -10.14%
07:41AM	The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts Benzinga
Oct-27-20 07:56PM	Allakos Previews Preliminary Financial Results for the Three Months Ended September 30, 2020 GlobeNewswire
04:09PM	Allakos Announces Proposed Public Offering of Common Stock GlobeNewswire
Oct-26-20 07:00AM	Results from Prospective Prevalence Study Indicate that Eosinophilic Gastritis and Eosinophilic Duodenitis May be Significantly Underdiagnosed GlobeNewswire
07:00AM	Allakos Announces Results from a Phase 1 Study of Subcutaneously Administered Lirentelimab (AK002) GlobeNewswire
Oct-21-20 05:00PM	Allakos Announces Publication of Results from the Phase 2 Study of Lirentelimab (AK002) in Patients with Eosinophilic Gastritis and/or Eosinophilic Duodenitis (ENIGMA) in the New England Journal of Medicine GlobeNewswire
Aug-28-20 06:53AM	New Strong Sell Stocks for August 28th Zacks
Aug-10-20 08:00AM	Allakos Reports Second Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
Jul-18-20 09:55AM	Companies Like Allakos (NASDAQ:ALLK) Can Afford To Invest In Growth Simply Wall St.
Jul-05-20 03:31PM	Hedge Funds Dropped The Ball On Allakos Inc. (ALLK) Insider Monkey
Jun-16-20 06:30PM	SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of the Following Companies: Allakos, Inc. (Nasdaq - ALLK), Enphase Energy, Inc. (Nasdaq - ENPH), MoSys, Inc. (Nasdaq - MOSY) ACCESSWIRE
Jun-03-20 08:01AM	Allakos Initiates Patient Recruitment for AK002 Registrational Studies GlobeNewswire
May-21-20 08:01AM	Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the Digital EAACI Annual Congress 2020 GlobeNewswire
May-15-20 09:02AM	Why Allakos (ALLK) Stock Might be a Great Pick Zacks
May-14-20 12:00PM	All You Need to Know About Allakos Inc (ALLK) Rating Upgrade to Buy Zacks
May-11-20 12:40PM	DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile +19.42%
10:31AM	ALLK DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Allakos Inc. Investors of Class Action and Lead Plaintiff Deadline: May 11, 2020 ACCESSWIRE
10:03AM	ALLAKOS FINAL DEADLINE TODAY: ROSEN, A GLOBALLY RECOGNIZED FIRM, Reminds Allakos Inc. Investors of Deadline Today In Securities Class Action First Filed by Firm ALLK Business Wire
08:01AM	Allakos Announces a Presentation of Antolimab in Patients with Severe Allergic Conjunctivitis at the 2020 ASCRS Virtual Annual Meeting GlobeNewswire
08:00AM	Allakos Reports First Quarter 2020 Financial Results GlobeNewswire
May-10-20 07:20PM	DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
05:10PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Allakos (ALLK) Investors: Important Application Deadline Tomorrow, Investors with Losses Should Contact its Attorneys Now ACCESSWIRE
02:11PM	ALLK FINAL MONDAY DEADLINE, ROSEN, FIRST FILING FIRM AND GLOBAL COUNSEL, Encourages Allakos Inc. Investors to Contact Firm Prior to May 11 Deadline For Class Action Seeking Recovery of Investor losses - ALLK ACCESSWIRE
01:45PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK ACCESSWIRE
01:30PM	FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
May-09-20 02:43PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates ALLK, CRON, FNKO Investors: 2-DAY APPLICATION DEADLINE ALERT, Investors with Losses Should Contact Firm Immediately GlobeNewswire
12:22PM	ALLAKOS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm GlobeNewswire
12:00PM	2-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
07:20AM	FINAL DEADLINE MAY 11: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
May-08-20 04:00PM	Safirstein Metcalf LLP Announces That A Class Action Has Been Filed Against Allakos, Inc. - ALLK GlobeNewswire
01:55PM	FINAL DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
01:30PM	ALLK INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Allakos Inc. Shareholders of Class Action and Lead Plaintiff Deadline: May 11, 2020 ACCESSWIRE
01:23PM	ALLK INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors that only 3 Days Remain to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Allakos Inc. GlobeNewswire
12:00PM	ALLAKOS FINAL DEADLINE, ROSEN, A TOP RANKED FIRM, Encourages Allakos Inc. Investors to Contact Firm Prior to May 11 Deadline For Class Action First Filed by Firm Seeking Recovery of Investor losses ALLK GlobeNewswire
10:55AM	Allakos Class Action Reminder: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm Newsfile
09:38AM	DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
May-07-20 06:35PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Allakos (ALLK) Investors with Losses to Contact Its Attorneys: 4 DAYS to APPLICATION DEADLINE ACCESSWIRE +5.30%
02:15PM	4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
01:00PM	ALLK DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Allakos Inc. Investors of Class Action and Lead Plaintiff Deadline: May 11, 2020 GlobeNewswire
11:12AM	Allakos Shareholder Notice: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm Newsfile
10:18AM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK GlobeNewswire
09:27AM	MONDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
May-06-20 05:00PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Allakos (ALLK) Investors with Losses to Contact Its Attorneys: 5 DAY DEADLINE ALERT ACCESSWIRE
04:50PM	5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
01:27PM	ALLK INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Allakos Inc. Investors of Class Action and Lead Plaintiff Deadline: May 11, 2020 ACCESSWIRE
10:12AM	ALLK INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors That Only 5 Days Remain to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Allakos Inc. Business Wire
09:41AM	MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
May-05-20 05:10PM	6-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
04:10PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK ACCESSWIRE
09:17AM	Allakos Shareholder Notice: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm Newsfile
09:00AM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Allakos (ALLK) Investors with Losses to Contact Its Attorneys: 7 DAY DEADLINE ALERT ACCESSWIRE
May-04-20 03:45PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates ALLK, CRON, FNKO Investors: 7-DAY APPLICATION DEADLINE ALERT, Investors with Losses Should Contact Firm GlobeNewswire
01:26PM	ALLK INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Allakos Inc. Investors of Class Action and Lead Plaintiff Deadline: May 11, 2020 ACCESSWIRE
09:29AM	7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
09:24AM	Allakos Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm Newsfile
08:01AM	Allakos Announces Positive Interim Results from an Open-Label Extension Study of Antolimab (AK002) in Patients with Eosinophilic Gastritis and/or Eosinophilic Duodenitis GlobeNewswire
May-03-20 05:16PM	ALLK DEADLINE: ROSEN, FIRST FILING AND TOP RANKED FIRM, Encourages Allakos Inc. Investors to Contact Firm Before Imminent Deadline in Class Action Seeking Recovery of Investor Losses - ALLK ACCESSWIRE
02:25PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Allakos (ALLK) Investors with Losses to Contact Its Attorneys: 8 DAY DEADLINE ALERT in Securities Fraud Class Action ACCESSWIRE
01:50PM	FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
09:50AM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK ACCESSWIRE
May-01-20 02:15PM	SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE -8.52%
01:05PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK GlobeNewswire
09:56AM	Allakos Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm Newsfile
Apr-30-20 06:23PM	ALLK LOSS NOTICE: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Allakos Inc. Investors of the Important May 11 Deadline in First Filed Securities Class Action Commenced By the Firm ALLK GlobeNewswire
06:05PM	IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Apr-29-20 08:00PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK ACCESSWIRE
06:30PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Allakos (ALLK) Investors with Losses to Contact Its Attorneys: 12 DAY DEADLINE ALERT in Securities Fraud Class Action ACCESSWIRE
03:01PM	UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
11:00AM	ALLK INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Allakos Inc. Investors of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
09:45AM	Allakos Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in Allakos Inc. to Contact the Firm Newsfile
Apr-28-20 09:30PM	IMPORTANT MAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE -12.55%
04:34PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates ALLK, CRON, FNKO Investors: 13-DAY DEADLINE ALERT, Investors with Losses Should Contact Firm GlobeNewswire
Apr-27-20 06:35PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Allakos (ALLK) Investors with Losses to Contact Its Attorneys: 14 DAY DEADLINE ALERT in Securities Fraud Class Action ACCESSWIRE
12:45PM	MAY 11 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Apr-26-20 01:34AM	ALLAKOS DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm GlobeNewswire
Apr-25-20 09:29AM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK ACCESSWIRE
Apr-23-20 05:25PM	FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
03:30PM	ROSEN, A TOP RANKED FIRM, Reminds Allakos Inc. Investors of the Important May 11th Deadline in First Filed Securities Class Action by the Firm ALLK GlobeNewswire
Apr-22-20 07:28PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates ALGN, ALLK, CRON, VMW Investors, Encourages Investors with Losses to Contact Firm, Reminds of Critical Upcoming Deadlines GlobeNewswire
04:28PM	ALLK INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of a Filing Deadline in a Securities Class Action Lawsuit Against Allakos Inc. ACCESSWIRE
10:20AM	WWE & ALLK INVESTOR NOTIFICATION: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
Apr-21-20 08:01AM	Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the 2020 DDW Annual Meeting GlobeNewswire
Apr-20-20 12:15PM	IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Apr-18-20 06:08PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK ACCESSWIRE
Apr-17-20 05:45PM	SHAREHOLDER DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Apr-16-20 08:03AM	ALLK INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of a Filing Deadline in a Securities Class Action Lawsuit Against Allakos Inc. ACCESSWIRE
Apr-15-20 07:30PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Allakos (ALLK) Investors with Losses to Contact Its Attorneys Now: Securities Fraud Investor Deadlines Pending GlobeNewswire -5.69%

Allakos Inc. operates as a clinical stage biopharmaceutical company. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; and a Phase II/III study for the treatment of eosinophilic esophagitis. The is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, severe allergic conjunctivitis, chronic urticaria, and indolent systemic mastocytosis. Allakos Inc. was incorporated in 2012 and is headquartered in Redwood City, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Tomasi Adam	President, COO and CFO	Apr 14	Option Exercise	0.69	20,000	13,750	173,126	Apr 14 08:00 PM
Tomasi Adam	President, COO and CFO	Apr 14	Sale	107.77	20,000	2,155,400	153,126	Apr 14 08:00 PM
Tomasi Adam	President, COO and CFO	Apr 13	Option Exercise	0.69	20,000	13,750	173,126	Apr 14 08:00 PM
Tomasi Adam	President, COO and CFO	Apr 13	Sale	103.08	20,000	2,061,600	153,126	Apr 14 08:00 PM
Tomasi Adam	President, COO and CFO	Apr 12	Option Exercise	0.69	20,000	13,750	173,126	Apr 14 08:00 PM
Tomasi Adam	President, COO and CFO	Apr 12	Sale	104.40	20,000	2,088,000	153,126	Apr 14 08:00 PM
RASMUSSEN HENRIK S MD	Chief Medical Officer	Apr 06	Option Exercise	1.16	10,000	11,625	111,819	Apr 06 08:00 PM
RASMUSSEN HENRIK S MD	Chief Medical Officer	Apr 06	Sale	111.68	10,000	1,116,800	101,819	Apr 06 08:00 PM
RASMUSSEN HENRIK S MD	Chief Medical Officer	Apr 05	Option Exercise	1.16	20,000	23,250	121,819	Apr 06 08:00 PM
RASMUSSEN HENRIK S MD	Chief Medical Officer	Apr 05	Sale	113.06	20,000	2,261,200	101,819	Apr 06 08:00 PM
RASMUSSEN HENRIK S MD	Chief Medical Officer	Apr 01	Option Exercise	1.16	20,000	23,250	121,819	Apr 06 08:00 PM
RASMUSSEN HENRIK S MD	Chief Medical Officer	Apr 01	Sale	114.40	20,000	2,288,000	101,819	Apr 06 08:00 PM
MCKEARN JOHN P	Director	Mar 26	Sale	115.00	7,439	855,485	1,200	Mar 30 09:18 PM
JANNEY DANIEL	Director	Mar 26	Sale	115.17	17,308	1,993,293	56,293	Mar 30 06:27 PM
JANNEY DANIEL	Director	Mar 22	Sale	119.70	13,148	1,573,790	73,601	Mar 24 07:21 PM
Alexander Robert	Chief Executive Officer	Mar 17	Option Exercise	0.69	20,000	13,750	265,395	Mar 17 08:00 PM
Alexander Robert	Chief Executive Officer	Mar 17	Sale	121.14	20,000	2,422,800	245,395	Mar 17 08:00 PM
James Steven P	Director	Mar 16	Option Exercise	0.53	3,500	1,838	3,500	Mar 17 08:00 PM
Alexander Robert	Chief Executive Officer	Mar 16	Option Exercise	0.69	20,000	13,750	265,395	Mar 17 08:00 PM
Alexander Robert	Chief Executive Officer	Mar 16	Sale	121.76	20,000	2,435,200	245,395	Mar 17 08:00 PM
James Steven P	Director	Mar 16	Sale	121.65	3,500	425,775	0	Mar 17 08:00 PM
Alexander Robert	Chief Executive Officer	Mar 15	Option Exercise	0.69	20,000	13,750	265,395	Mar 17 08:00 PM
Alexander Robert	Chief Executive Officer	Mar 15	Sale	122.78	20,000	2,455,600	245,395	Mar 17 08:00 PM
JANNEY DANIEL	Director	Mar 15	Sale	124.56	6,708	835,548	86,749	Mar 16 04:17 PM
JANNEY DANIEL	Director	Mar 12	Sale	124.18	4,071	505,537	93,457	Mar 16 04:17 PM
JANNEY DANIEL	Director	Mar 11	Sale	124.62	6,006	748,468	97,528	Mar 11 07:35 PM
Hudson Peter A	member - potential 10% group	Mar 11	Sale	123.92	20,247	2,509,105	8,000	Mar 11 07:28 PM
Tomasi Adam	President, COO and CFO	Mar 10	Option Exercise	0.69	20,000	13,750	173,126	Mar 10 08:00 PM
Hudson Peter A	member - potential 10% group	Mar 10	Sale	124.37	2,107	262,048	28,247	Mar 11 07:28 PM
Tomasi Adam	President, COO and CFO	Mar 10	Sale	121.78	20,000	2,435,600	153,126	Mar 10 08:00 PM
Tomasi Adam	President, COO and CFO	Mar 09	Option Exercise	0.69	20,000	13,750	173,126	Mar 10 08:00 PM
Tomasi Adam	President, COO and CFO	Mar 09	Sale	121.78	20,000	2,435,600	153,126	Mar 10 08:00 PM
JANNEY DANIEL	Director	Mar 09	Sale	125.00	100	12,500	103,534	Mar 11 07:35 PM
Hudson Peter A	member - potential 10% group	Mar 09	Sale	124.75	2,200	274,446	30,354	Mar 11 07:28 PM
Tomasi Adam	President, COO and CFO	Mar 08	Option Exercise	0.69	20,000	13,750	173,126	Mar 10 08:00 PM
Tomasi Adam	President, COO and CFO	Mar 08	Sale	122.78	20,000	2,455,600	153,126	Mar 10 08:00 PM
MORE ROBERT J	member - potential 10% group	Mar 05	Sale	117.78	12,676	1,493,040	0	Mar 05 07:42 PM
MORE ROBERT J	member - potential 10% group	Mar 04	Sale	111.55	15,000	1,673,184	12,676	Mar 05 07:42 PM
NOHRA GUY P	10% Owner	Mar 04	Sale	111.64	25,768	2,876,742	0	Mar 08 08:40 PM
RASMUSSEN HENRIK S MD	Chief Medical Officer	Mar 03	Option Exercise	1.16	20,000	23,250	123,771	Mar 03 09:55 PM
MORE ROBERT J	member - potential 10% group	Mar 03	Sale	113.18	4,878	552,094	27,676	Mar 05 07:42 PM
Tomasi Adam	President, COO and CFO	Mar 03	Sale	113.56	3,189	362,143	153,126	Mar 03 09:59 PM
RASMUSSEN HENRIK S MD	Chief Medical Officer	Mar 03	Sale	112.98	21,952	2,480,244	101,819	Mar 03 09:55 PM
RASMUSSEN HENRIK S MD	Chief Medical Officer	Mar 02	Option Exercise	1.16	20,000	23,250	125,087	Mar 03 09:55 PM
RASMUSSEN HENRIK S MD	Chief Medical Officer	Mar 02	Sale	117.32	20,000	2,346,400	105,087	Mar 03 09:55 PM
RASMUSSEN HENRIK S MD	Chief Medical Officer	Mar 01	Option Exercise	1.16	20,000	23,250	125,087	Mar 03 09:55 PM
RASMUSSEN HENRIK S MD	Chief Medical Officer	Mar 01	Sale	120.66	20,000	2,413,200	105,087	Mar 03 09:55 PM
Walker Paul Edward	Director	Dec 31	Sale	140.46	35,023	4,919,378	2,163,260	Jan 04 05:51 PM
Walker Paul Edward	Director	Dec 30	Sale	141.71	68,392	9,691,853	2,198,283	Jan 04 05:51 PM
Tomasi Adam	President, COO and CFO	Dec 29	Option Exercise	4.31	5,416	23,356	157,757	Dec 31 09:04 PM
Alexander Robert	Chief Executive Officer	Dec 29	Option Exercise	4.31	8,240	35,535	241,105	Dec 31 09:03 PM
NOHRA GUY P	10% Owner	Jun 17	Sale	75.62	7,692	581,693	0	Jun 19 07:24 PM
MORE ROBERT J	member - potential 10% group	May 18	Sale	71.58	11,538	825,939	0	May 20 06:08 PM
Hudson Peter A	member - potential 10% group	May 18	Sale	71.86	11,538	829,085	0	May 20 06:07 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience